>teicoplanin_2_1
GMGCNAGLNALNVVAGWSAAHPGELGVVLCTEACSAAYALDGTMRTAVVNSLFGDGAAALALISDAPGQS
>teicoplanin_2_2
LAGTGLRRRDIAQWLVHSGGKKVIDAVVVNLGLTRHDVRHTTRILRDYGNVSSGSFLFSYERLVEEGVTRPGDYGVLMTMGPGSTIETALVQW
>vancomycin_1
GTGLRRSDIGHWLVHSGGKKVIDAVVVNLGLSRYDVRHTTGVLRDYGNLSSGSFLFSYERLADEDVARPGDYGVLMTMGPGSTIEMALIQW
>mupirocin_1
CTMLLAGLEVARAQVLAGLDNVLVVSANRIEDEAFRFQHYALFSDGAASCLVTSGRRRGFEMLGSLARSN
>mupirocin_2
HRQQINTADLEQVVCSNVFLPVLKIKEGRQGVSGTQLYVDNVTRVGHCFSADSLINLCDYQARAQQVHGGLVMLTANADGLRCQTLL
>daunorubicin_1
EVRQVSNGGMAALELARAYLLAAPDRTAALVTTGDRMSPPGFDRWNRPRHVYADGGTALVLSRQGG
>daunorubicin_2
LKAAGVGLDDISRVVLPHMGWRRLSASYFGKWPVPPERTTWEFGRRTGHLGGGDPIAGFDHLVGSGRLAPGELCLLVSVGAGFSWSCAVVE
>ristomycin_1
GTGLRRSDIGHWLVHSGGKKVIDAVVVNLGLSRHDVRHTTGVLRDYGNLSSGSFLFSYERLADEDVARPGDYGVLMTMGPGSTIEMALIQW
>dutomycin_1
LEEAGIGRSDITRVAYVNYARLATQMWLLDPLGIPMSTSTWEIGRHIGHIGPSDQLVSLDRLLSRGELGPGDHVLLAGLGPGMTLGSAVLEI
>dutomycin_2
LTMGCLGGLTALEVAVGHLRGDASRRTVLFTSADNWSSPVVDRWRSFPGVILGDGASALTLGRGTGFARLLSVN
>U_68204_2_1
LQDLSVPPDQVRHFIPHQANGAMLGEVLENLGLPRARAHLPVGRHGNTGAASVPLALDHAHRSGELSDGDLVLLAGFGGGMTMSAALLAW
>U_68204_2_2
FDVNAVCAGFVVALDIAARMLAGDGASRGPALVIGSEVYSRVIDPTDRRTAPLFGDGAGAVVLGPVSGQRGVLGSHSTTD
>R1128_1
FDLSAACAGFCHALSIAADAVESGGSRHVLVVATERMTDVIDLADRSLSFLFGDGAGAAVVGPSDVPGI
>R1128_2
LEVAGLTVGDLVAFVPHQANLRIIDVLVDRLGVPEHVVVSRDAEDTGNTSSASVALALDRLVRSGAVPGGGPALMIGFGAGLSYAGQAL
>lipopeptide_8D11_1
AHAGWDLADVDAFVGHQANLRILTSVAKRLGLPRERVVSNIADVANTAAASIPLALADAAAEGRIGSGDRLLLTAFGGGLTWGSAAVVW
>lipopeptide_8D11_2
FDLSAVCSGFVYGLSVADAMITAGTCERALVIGADVYSSIVDPGDRGTAVIFGDGAGAVLLERGRTGEPGAVLHTELGSDG
>A_74528_1
LDLAGVTTDRLDAFIPHQANMLITDVVVEQLGLTERTSVARDIVTSGNSSAASIPLAMEELLSSGHAPSGGLALLVGFGAGLVYAGQVVR
>A_74528_2
FDVSAACAGFCHAVALASDLVGLARTDYVLVIGAERMTDILDHSDRDTAFLFADGAGAVVVGPSDEPGVGPVVWRADG
>thiomarinol_1
DCANLLSALDMTKQLIDSDKYPHIMLVTSNKISDERHRFQDYALFSDGAASIMISNKK
>thiomarinol_2
RNQITISDLSKVFSNNLYMPVITLKEGGIGVSKSQLYLDNIVRFGHCFSADSIINLADYLANSRVAAGEYFALHSSASGLRAQ
>quinocarcin_1
AQGCIGGITCLDQVAGRFATHPDYQNALVIGVNRTCEAYWNRMETHSLMFSDGAAAAVLRRGHDAYTWRAVETISDG
>quinocarcin_2
RIGADVSDLSRVVFLNDNARTLKDVSGKIGVPLDRTNFDISLEHGHFGAADHLFNLRRHILDDAVKPGDLIALAGMGRGMHWACALIE
>A40926_1
GMGCNAGLNALNLVAGWSAAHPGELAVVLCSEACSAAYALDGTMRTAVVNSLFGDGSAALAVVSGDGRAAGPRVLK
>A40926_2
GTGLRRSDIGHWLVHSGGKKVIDAIVVNLGLSRHDVRHTTAVLRDYGNLSSGSFLFSYERLAGEGVTRPGDYGVLMTMGPGSTIETALIQW
>xenocyloins_1
LSRHNLVPADIKGFMFSQFSVSNIRRLCEELGVDQDKALFIGDEYGYTATNSPFVALYETLERKKIVRGDFLIFWTIGAGWQSIAVLMQ
>xenocyloins_2
FDMNANCAGLLVAVEMVSRAMMASPSCQLALVVGSDYLGAHSSNAPVYHSCFAESAVAVILHKTEQGNGFIDSEFR
>xenocyloins_3
CQSNGMSLNEVSAFYVYDPSDWVASAAAEALGVGKDKIISIFHKYGSLGPAQSFFGFMEMQDNKNLTDSDWVIVMGLGPSTTATAVLFRW
>xenocyloins_4
INVGTSGGATGLEIATAMFANSEFHNIAVIAGCNYSHWFSMSDPARTLLSDGAACLVLSRKQGM
>abyssomicin_1
LQSGCSGAVQALAVTRSLLLGGTARTALVLGGDVVARFYDLTADLRKLPPAEFVNYVLFGDGVGAAVLRVGEVAGAAALR
>abyssomicin_2
ELGWARDDLDYVLPPQLSGRMTALIVERLKLPQATEVSCVAETGNNGNGIVFLQLERALARLAGGQRALGVS
>eponemycin_1
FDISAVCAGFLYGLATAAGLIASGTARQVLLIGADAFTTIVDPKDRSTAVIFADGAGAVVLRAGRADEPGAVGPVVLGSDG
>eponemycin_2
ESAGWSLEDVDRFAAHQANARILEAVADELAIPAGHRLSNISRVGNTGAASIPLLLAQAAEDSSLAEGHRTLLTAFGGGLAWGAATLTW
>A33853_1
EIRQGCLGMVAGLEAAACRLSLDRYTGGEGGDSVLLTTGDNFSTPMVDRWTSSKLFLFGDAGSSLVVSRRPGFARVL
>A33853_2
AEAGVALSDIRRFCHVGFNEDPLLTMFLEPLGVSLEQGTWDICRRIGHTGVSDFVISLERLWLDGEVGPGDHVMLIGAATGMEAGCAVLEI
>naringenin_1
QLGCAAGGAAVNRAHDFCTAYPGTNVLIVACEFCSLCYQPTDLGIGSLLSNGLFGDGIAAAVVRGEEGTG
>naringenin_2
EQHQWNAGKLDFYIIHAGGPRILDDLSRFLDVPPGAFRHSRATLTEYGNIASAVVLDALGRLFDEQSALDGHHGMLAGFGPGIIAE
>maklamicin_1
LDEAGIGIADVTRVAPMNFSRALIERLMGGLGLTMAHSTWAWGSTVGHLGASDQVVALDHLLATGDLGPGDHLLMLGIGPGVTLSCAVVG
>maklamicin_2
LHHGCNGMFTALELAASYLHAHPDRHTALLVAADNFGTPMMDRWRSGHEHLIGDAGSAVVLTTR
>maklamicin_3
MQSGCTGAVQALDVAHKLLLVGRGRTALVLGADSCAKHLDVHADTTGADPAEQVNGVLFGDGAGAAVLRTEPVP
>maklamicin_4
LDELDWQDDEVDYLLPPQLSGRMTARITAALGLPGAYEVSCVADIGNTGNALPFFQLEQVMPKMAAGDRAVGVA
>maklamicin_5
LHHGCNGMFTALELAASYLHAHPDRHTALLVAADNFGTPMIDRWLGGPGYLMGDAGSALVLTTR
>maklamicin_6
LAEAGIDISDVTRVAYMNYSREIVEQRCTAALGLPLSASTWDWGRGLGHLGASDQVAALDHLIGTGQLGPGDHLLMLGVGPGVTVSCAVVQI
>corallopyronin_1
DITIKDCRYVIPHQPSRVVLDYLSLTYPDDKLVRIIDRFANCIGASMPMALYEAVKVGGLRRGERGVLTGTGSGVSFVGMVFT
>corallopyronin_2
VNASCLSFFVALDVAANYLNMRRYKRILIVSSDISSVALDFRKPENFTLFGDAAAAAVVTLPEPGEKSCIHASQVR
>2_4_diacetylphloroglucinol_1
DVQFAGKSGTSALQIAYALVASGMVGNALAVGADTINRNTAPGDLTESYAGAGAAALLLGTE
>2_4_diacetylphloroglucinol_2
AKIHAQADDFDYVVFQQNLVSTPYSLGKHLGFTKAQIEPGIYAQSVGDAGAASPLLGLVNVLDQARPGERILVVSYGFGAGSD
>2_4_diacetylphloroglucinol_3
QLGCVAGAAAINRANDFASLAPDNHVLIVSLEFSSLCYQPQDTKLHAFISAALFGDAVSACVMRADDQASGFKI
>2_4_diacetylphloroglucinol_4
DFFIFHTGGREILDELVLQLDLEPGRVAQSRDSLSEAGNIASVVVFDVLKRQFDSGPVNGATGMLAAFGPGFTAEMAVGKW
>PQS_1
DSQMECASFLLNLRLAASMIRQGKAEKVLVVCSEYISNLLDFTSRTSTLFADGCAVALLTRGDDDSCDLLASAEHSD
>PQS_2
LEKAGLGSDDIDYFVFHQPAPFLVKAWAEGIGARPEQYQLTMGDTGVMISVSIPYTLMTGLREGKIRPGDRIVMAGAATGWGFAAQVWQ
>PQS_3
LDIRAQCSGLLYGLQMARGQILAGLARHVLVVCGEVLSKRMDCSDRGRNLSILLGDGAGAVVVSAGESLEDGLLDLRLGADG
>PQS_4
LAAHELTLDDIDHVICHQPNLRILDAVQEQLGIPQHKFAVTVDRLGNMASASTPVTLAMFWPDIQPGQRVLVLTYGSGATWGAALYR
>colabomycin_1
EALQLADLLLDEEEVEQVLVIGVETAANERVDWVRERVGSARLFGPLPQGDAAVALLLRRWNAD
>liposidomycin_1
ELKQACYGATAALQFAVGLVLRDPAQQVLVVASDISKYDLESPGEATQGAAAVAMLVCS
>liposidomycin_2
SSACAGGTQALIRAADQLAARPGGKVLVVVAEALSTIYHAHEDNIESMIYKVLFGDSAGACVVTDVPL
>teicoplanin_1
GMGCNAGLNALNVVAGWSAAHPGELGVVLCTEACSAAYALDGTMRTAVVNSLFGDGAAALALISDAPGQS
>teicoplanin_2
LAGTGLRRRDIAQWLVHSGGKKVIDAVVVNLGLTRHDVRHTTRILRDYGNVSSGSFLFSYERLVEEGVTRPGDYGVLMTMGPGSTIETALVQW
>endophenazines_1
ELKQACYGATAALQFALGLIHRDPTQKVLVVASDVSKYELDSPGEATQGAAAVAMLVTAD
>myxovirescin_2_1
EVKQACYAATGALQLALGYIASGVSPGAKALVIATDVTLVDESGLYSEPAMGTGGVAVLLGDEPRVMKMDLG
>myxovirescin_2_2
ELKSACYSGVAGLQMAVNFILSGVSPGAKALVVASDLSRFSIAEGGDASTEDWSFAEPSSGAGAVAMLVSDTPRVFRVDVGAN
>aclacinomycin_2_1
EVGQVSNGGMAALGLAVDHLSAGRPAEAGRRVLVTTGDAFRPPGFDRWRSDPGTFYGDGGTALVLSSGEGFARI
>aclacinomycin_2_2
LAAAGAGLADIDRFVLPHMGRKRLRAGFLNRLGIGEDRTTWEWSRGVGHLGAGDQIAGFDHLVGSGSLGPGDLVLWMSVGAGFTYSCAVVEM
>diaphorin_1
FELKQACYSCTAGLQMAINFILSKVSPGAKALVIATDISRFFVTEDKNELTMEWAFFEPSGGAGAVAMLISDKPEIFQFDIGSNG
>skyllamycin_1
SNACSASLYALALAFDQLQSGSVEHVIVAGADSITESMFGLTDAFQLEPPGRLRPFDVDRKGTILGEGAGAIVLGRTPGDR
>skyllamycin_2
ASGLDALRWAATMLNAGRADQFLVIGVEPDNEMVRKLVGADRIVDGAVAVVLEREETAQER
>rishirilide_b_1
IKQLSNGGMAALELASAYLAGAPGPTAGLLTTGDVFTDPGFDRWRSDPGTVYGDAGTALVLARGRGGFARLRSLVTVS
>rishirilide_b_2
LAEADCTLADLSWFVLPNFGRGRLNSTFLRRWSIEEERTTWRWGRSVGHLGAGDQFAGLAFLAESGRARAGELGLLFGVGAGFTWSCAIVE
>red_pigment_1
QLGCAAGGAAINRAHDFCTAYPDANALIVSCEFCSLCYQPTDDDIGSLLSNGLFGDAVGAAVVRGHGGTG
>red_pigment_2
DHRWDVAGLDFYVIHAGGPRILDDLTKFLGVPSEAFRHSRATLAQYGNIASAVVLDALRRIIEEGRLESGARGMIAGFGPGITAEMSV
>phenalinolactone_1
EVRNGCNGTFGALELAAGYLKAFPHVPAALVTASDNFGTPLIDRWNPGDGVAYLGDGASAVVVSTTP
>phenalinolactone_2
LEEAGVTADDITHVLIHGMPRRAAASYLRILGFPLERSTWDFSRTVGHLGASDHMAALHHLLATERLHAGDHVLLCGFSPGVTYKAAVVR
>frenolicin_1
LRESGIEPEALDAFVPHQANLRMIELMAERLGLPERTAVARDVVRAGNTSAASVPLALEALLDSGEVGSGDRALLVGFGAGLNYAAQVVE
>frenolicin_2
LDVSGACAGFCHALALASDAVRAGSARHVLVVGTERMTDLVERADRTVSVLFADGAGAAVVGPSARPG
>pactamycin_2_1
EAGITVPDLSHVLHLGAATTDFLDSHLRPMGLDASLGSVEFFRDVGHHAGAADVGIHLDHLACSGRLAAGDHLLMLSAGPGLMITAAVVT
>pactamycin_2_2
VEQGCNAFLAALEMATQYLLCAPTRSGAVVSAADNFGAPSVDRWHAHRDSVLADAGAAVVLSKR
>cinerubin_1
LASAGVALGDVDRFVLPHLGRKRLRAGFLARFGIAEERTTWEWSRTVGHLGAGDQFAGFDHLVSSGTLAAGDLVVWMSVGAGFTYSCAVVEI
>cinerubin_2
EVGQVSNGGMAALGLAVDHLRGGAADGAEDRRVLVTTGDAFRPPGFDRWRSDPGTFYGDGGTALVLSSRRGF
>herboxidiene_1
GWDISDLDFYIVHAGGPRILDDLSKYLMLPSETFRYSRATLTERGNIASAVIFDALDRLFEEGGAAEGARGLIAGFGPGITAEISLGRW
>tetronasin_1
VQSGCAGVVQAMEIAVQRLAGGSARTALVLGGDTWVKHFDPSGDIKHLSPAELVSMALAGDGAGCAVLSVEPRPGAA
>tetronasin_2
LDDVGWKDSDVDAVLPPQHSGRVTERVCELLGVAESSVTSRVEETGNNGNGLLLFQLERALAGLGSGGRVV
>tetronasin_3
LQSGCTGAVQALEITQDLLRGGAYRTALVIGGDTSAKHTSPDVDAASVPLEVQVNGLIFGDGVGAAVLGTAPAEGRPVL
>tetronasin_4
LHELSWDAEQVRYILPPQLSARMTDRTLSHLALPGSEPISRVTEIGNTGNAIPYFQLELLLPRLNPGDRAVGIS
>coumermycin_1
LRHGCNGTFSALELAVPYVKCAPHAGGVLITASDNFGTPLIDRWNPGEGMAYLGDGAGAVVLGSSPGFAELLS
>coumermycin_2
LHEAGVDARDIKTVLIHSMPRQAAASYLKILGFSLDRSTWEFSRTTGHLGAGDHLAALYHLLSTGEVGPGDNLLLCGSSPGVTYKAAVIRI
>sanglifehrin_a_1
TQGCASAVTAFQQIAGIFATRPDAETVLLVAVNQVSEAHTNRMRFNTLLGSDGAAAAVLRRGHDRLRWLATEQLT
>sanglifehrin_a_2
DGAGVDPGQVKRFLFLNDNQDSLADVAKAVGVPLDRTNAELAKDLGHCGGADQLICLDTLLERGELAEGDVVALAGLSIGMHWYCTLLT
>oxazolomycin_1
LADAGIGKDDVAATLMQNVTSSAFDFYKATLGLPIHPVCATHLAELGHLGPMDVVLNLDRLLATGEVGPGGHVLVLSNSPVAAWTVTLW
>SF2575_1
FDVNAVCSGFVYALSIADAMLARDGGTALVVGADMYSSVMDRSDRRTVSLFGDGAAAMLLGEVPDGYGIHATSLLADG
>SF2575_2
SAGVSADDVDRFIVHQGNARLVESVADLLGVEMARVPLSAPLYGNTGAAALPLTLHHSHRERPLERGERILFAAVGGGMTAGAALLTW
>SF2575_3
ELRTGCSGMLSSVELAVAQLTGAQRYSNVLLTAAENFDPWMERWKSDVYITGDAASALLLSSTSGFARVVSAAS
>SF2575_4
GGIKLADVDKLVYHNMAGFIVGFFAEQMGLSLEHSTWEFGRTLGHLGCSDQAVGLEHLLLTGELSPGDRVMLLAASAGFATSCILLEI
>polyketomycin_1
AATGLGVEDVTFLSYMNTSRTTIEKRLLPLLGLPAERTTWEVGRDIGHLGVSDQLVALDRLLCDGRLKPGDHYLMYGLGPGMTVAGAMFEI
>polyketomycin_2
LRHGCTGVFSGLQLAAGFLRGNPQSSDALLLGAENFGTPLIDRWRATGGGMLVGDGASALLLGKE
>aresnopolyketides_1
WQACSGLIGSLELAACYLKAVPERSAALLTGADNVGTPNFNRWAFGIQNGVLGDGGSAILLSKSEGFASLLSINTGS
>aresnopolyketides_2
LAEAGLEPGDVTRVCHVFTGQESYLKVILDPMGLSPDQGLLDFGRNLGHMTVNDQIVGLTHLVETGQVGPGDHVLIVAHGGGVSITCAVVRI
>avilamycin_1
EIRQGCNGVFSALELAVGYLQADPNRTSALIVAADNYGTPLIDRWRMGPGFIGGDA
>avilamycin_2
LAGAGIGMADVARVSFMNYHAKWSSSAEWRPGGCRCPGPRGNSAGRSATCGASDHLLSMEHIVRTGELAPGDHVLQLATAPGLVVSSAVLQ
>argimycin_1
FDLGAACAGFSHGLALAGSLVVAGQAEHVMVIGAERMSDIVDPRDRSTAFIFGDGAGAMLVGRSAEPGIGQVAWGT
>argimycin_2
LESAGVDSGDIEAFVPHQANGRIIDAVVKNMKLPASVAVARTIREDGNTSAASVPLAMDHLVSTGQVRRGGLALTVGFGSGLGYSAQVIT
>undecylprodigiosin_1
FDVSAVCSGFLYGLATGSGLIASGAAERVLVIGAETFSRILNPQDRSTSVIFGDGAGAVVLRAGEPGETGALGPLRLGSDG
>undecylprodigiosin_2
LDRAGWRVADVDWLVSHQANHRITARLADEIGIPRERSVSNIAEVGNTAAASIPLALDHAHARGTLRPGDRVLLTAFGGGLTWGAAALTW
>divergolide_1
FDLNAVCAGFVYGLEAARGLIAVRPGAHVLLIGADVYSRFLDFTDRRSAVLLGDGAGAVVVGAVEDGNGILGIDLSTRG
>divergolide_2
LAGAGVRAEEIDCFVPHQANAVLIRELAARCGLADTPLVQVVETYGNTGAASVPIGLDHAVREGTVEPGGLVLLSAFGAGMSVGNGLLRW
>esmeraldin_1
LAEVGLTMDQVARVTHVGFHHGSLHALYLEPLGIDADRGTWEHSRRIGHASMSDVVIGLEHLWLTRQVNPGDRVLMIGTTPGMEVGCAVVEI
>esmeraldin_2
IQQGCNGLMTGIEMAAHRLMASPDKDAALVTGADNFNTPLVDRWRASGLFFMADSGSAIVVSRRGGFAKVLAV
>lipstatin_1
FDVSNACAGMMTGVWLLDRMIRSGAVRSGMVVSGEQATRVARTAARELRDSYDPQFASLSVGDSAAAVVLDESTDPADRIHYIEL
>alnumycin_1
DLSAACAGFCHALAMASDAVRAGSARRVLVVGAERMTDIVEPTDRTISFLFADGAGAVVVGDSDTPGIG
>alnumycin_2
REAGLTPAELGAFVPHQANLRMIELMTERLGLTGATAVSRDVVRSGNTSAASIPLALEALLASQEASTGDTALLVGFGAGLNFASQVV
>viguiepinol_1
ELKQACYGATAALQFAIGLVRRDPDQQVLVIASDVSKYELDSPGEATQGAAAVAMLVSAD
>viguiepinol_2
FDVNAVCSGMVFALAAAEGVLTRTGGHALVIGADLYSRILNRADRRTVILFGDGAGAVILGSSVDHGPRIRHLALHS
>viguiepinol_3
LHKCGVVPDDIDHFVPHQANGTMLDSLFADLELPRATMHRTLTHYANTGAASIPITLDAAARAGAFNPGDLILMAGFGGGMSAGFALVEW
>nataxazole_1
LKQADVSWDQIAKVCHVGFGRPALEAMFLLPLDVPEEKTVWEYANTIGHTGAADLFLGLEHVWRTGQVGPGDHVLLIGASTGMEAGAAVVRI
>nataxazole_2
EIKQGCLGMLASLDVAAARLIANPTHDAALITTGDNYSTPGVERWRASGLFVLADAGSAVVLSRRGGFAELLAL
>lasalocid_1
DIAPDAVDHFVPHQANGMMLREVLPLLGLPRARTHLTVAEHANTGAASVPLALDTVRRGGLLEDGDTVLLAGFGGGMSLGTALVRW
>simocyclinone_4_1
DRAGCTLDDIQVVIAPNPNTTLWQDTIKDEALRSKFFFDNIPRYSHCLASDVLINYATLGEEKRFEPDRPAMFVAIGVGMTFSAMVF
>calicheamicin_1
EIRQGCNGMFTMLELAASYLKAAPERKAAMLVAADNYGTPLLDRWRTNLGFILGDAASAVVLSTESGFVEL
>calicheamicin_2
LAEAGIGTGDLAKVSFMNYSREVVEQRCMAPLGLGMEKSTWDFGRMIGHCGASDHLLALHHSLRAGEVAAGDHVLWLAMGPGVEFTAAVLR
>balhimycin_1
GTGLRRSDIGHWLVHSGGKKVIDSVVVNLGLSRHDVRHTTGVLRDYGNLSSGSFLFSYERLAEEGVTRPGDYGVLMTMGPGSTIEMALIQW
>marineosin_1
DVSAVCTGFLYALASGAGLIAAGGAERVLVIGAETFSRILNPADRSTSVIFGDGAGAVVLRAGDPDEVGALGPFDLGSDG
>marineosin_2
LDRTGWRVEDVDHLVAHQANHRITRRLADEIGLPRERAVSNIAEVGNTAAASIPLALAHAHAAGALTPGDRVLLTAFGGGLTWGATTLTW
>tiacumicin_1
EIRQGCNGMFSAMMLAVSHLRADEDRRHALLVAADNYGTPMMDRWRMNPGTVAGDAGSAVVLTKDPGYAQLLA
>tiacumicin_2
AECGLALSDLDRVAFMNYSREVVEQRCMAPLGLPMARSSWDYGRTIGHCGASDHVLSLKHFVDTGQLRPGQHMLLLGTGPGINLACAVIKI
>prodigiosin_1
YDVSAGFGGFLYGLATAAGLIGCGAAERALVIGADTLSRRLDPADRPTAVSYGDGAGAVLLRAGEPDEPGALGPVSLGSDG
>prodigiosin_2
LDRAGWPAGDVSHLVTHQANHRIVERLADELGIPRERGICNISEVGNTATASLPLTLGHAHAARLPKPGDRVLLTAFGGGLTWGATVLTW
>calcium_dependent_antibiotic_1
AHAGWDLADVDAFVGHQANLRILTSVAKRLRLPPERVVSNIADVANTAAASIPLALADAAAQGRIGSGDRLLLTAFGGGLTWGSAAVVW
>calcium_dependent_antibiotic_2
FDLSAVCSGFVYGLSVASAMITAGTCDRALVIGADVYSSIVDPDDRGTAVVFGDGAGAVLLERGDTGDPGAVLHTELGSDG
>napyradiomycin_1
ELKQACYGATAALQFAIGLIRRDPTQHVLVIASDISKYDADSPGEATQGAAAVAMLVSTN
>napyradiomycin_2
HSWDAGKLDFYIVHAGGPRILDDLARFLDVDRQVFRHSWSTLTEYGNIASAVVFDAARRLFEEGSAKPDATGMIAGFGPGITAEMALG
>simocyclinone_1
QQNCAIALSAIDIAGTLLQADGDPDARVLVVTGDKPRHRAAQLVMNTCVVGDGAASALVSWNGSG
>simocyclinone_2
DRAGCTLDDIQVVLAPNPNTTLWVDTIKDDALRSKFFFDNIPRYSHCLASDVLINYATLCEEKRFEPGRPAMFVAIGVGMTFSAMVF
>benastatin_1
IERAGVTSEELSAFIPHQANGLITDALAKDIGLTADTAIARDITDSGNTSGASIPMAMERLLASGQARSGEAALLIGFGSGLVHAGQVV
>benastatin_2
FDLSAACAGFCHGVAIADSMVRSGTAHNVLLVGADRMTDVVDADDPATAFLFADGAGAVVIGPSETPGIGPVAWGSDG
>feglymycin_1
GMGCNAGLNALGVVSGWATAHPGELAVVLCAEACSAAYAMDSTMRTAVVNSLFGDGAGAVALMSGQ
>feglymycin_2
QGTALRRSDIKHWLVHSGGKKVIDAVIVNLGLTRYDLRHTVGVLRDHGNVSSGSFLFSYERLLDEKVTQPGDYGVLMTMGPGSTIETALVQW
>aclacinomycin_1
EVGQVSNGGMAALGLAVDHLSAGRPAGAAGRRVLVTTGDAFRPPGFDRWRSDPGTFYGDGGTALVLSSQEGFARI
>aclacinomycin_2
LAAAGAELADIDRFVLPHMGRKRLRAGFLNRLGIGEDRTTWEWSRGVGHLGAGDQIAGFDHLVGSGSLGPGDLVLWMSVGAGFTYSCAVVEM
>myxovirescin_1
EVKQACYAATGALQLALGYIASGVSPGAKALVIATDVTLVDESGLYSEPAMGTGGVAVLLGDEPRVMKMDLG
>myxovirescin_2
ELKSACYSGVAGLQMAVNFILSGVSPGAKALVVASDLSRFSIAEGGDASTEDWSFAEPSSGAGAVAMLVSDTPRVFRVDVGAN
>reveromycin_1
LAAAGTDPAELGAFIPHQANLRIVDAAVAALGLPPHVAVSRDVTDTGNTSAASIPLAMERMVAQGRAGSGDLALLVGFGAGLTHAAMVVA
>reveromycin_2
MDVSAACAGFVHALAVADALIRTGAARRVLVVGSEKMTDIIDLRDRATAFLFGDGAGAVVVGPADTPGIGPVVWGSDG
>leinamycin_1
EVKQACFGATAAVQTAVGYLASGISPGAKALVIATDVAVVDEKAEYSEPAAGHGAAAMLLSDRPRVLAMDLG
>cystargolide_1
AVGWRTEQIDAFVGHQANARILRAVGRRLGLAEERVVCRLAEVGNTAGASIPLALAQAAADDRLSKGDRVLMTAFGGGLTWGSAAMVW
>cystargolide_2
FDLSAVCSGFVYGLSVAGAMIGAGSYESVLLIGAETYSTIVDPADRGTAVLFGDGAAAVVLERGLPGTPGELLHVELGSDG
>alkyl_o_dihydrogeranyl_methoxyhydroquinones_1
LAKRGLRIADIDGWAVHPGGPKILDVVQERLELDDAALAPSRGVLEAYGNCSSATVLLVLDALRRQEDPPRRIVMLAFGPGLTLYVTLL
>alkyl_o_dihydrogeranyl_methoxyhydroquinones_2
MGCYAALPGLGTVSDFVVARGRPALLLCAELTSLHLQPAGTRTDIQQIVSHALFSDAAAACVVTPGGFGYGVSEVAA
>thiotetroamide_1
FDVNAVCAGFVVALRAGASMTLEDGRHGGRALVIGSDVYSRIVDPSDRRTAPLFGDGAGAVVLGPVAEAGGLLGGSVAT
>thiotetroamide_2
LSVPPEEIRHFIPHQANGAMLRDIWGHLGLPHAHLHMPVARHGNTGAASIPIALDHAHRSGRLAAGELVLLAGFGGGMTMGTSLISW
>merochlorin_1
LHEAGVTPDDIRHFVPHQANGRLLETVFTDLALPNATMHQTLTHYANTGAASLPITLDAAARQGAFHPGDLVLLAAFGGGMAAGLALIEW
>merochlorin_2
FDVNAVCSGTVFALSAAEGILARQGGHALVIGADIYSRILNPTDRKTVILFGDGAGALVLGATGQGPRIRHMTQ
>merochlorin_3
ELKQACYGATAALQFAIGLVRRDPAQRVLVIASDVSKYELDSPGEATQGAAAVAMLVGAD
>merochlorin_4
QLGCAAGGAAINRAHDFCMAHPGSNVLIVSCELCSLCYQPDADDIGSLLSDGLFGDAVAAAVVRGNG
>merochlorin_5
HSWDVGNLDFYIIHAGGPRILDDLAKFLDVDRQVFRHSWATLTEYGNIASAVVLEAARRLFEEDTPKPDATGLIAGFGPGITAEMALGRW
>doxorubicin_1
EVRQVSNGGMAALELARAYLLAAPDRVAALITTGDRMHPPGFDRWSSDPGTVYADGGTALVLSRQGG
>doxorubicin_2
LEAAGAGLDDISRVVLPHMGWRRLSAAYFNKWHIQPERTTWEFGRRTGHLGGGDPIAGFDHLVGSGRLAPGELCLLVSVGAGFSWSCAVVE
>lobophorin_1
LDALNWDRGEVDYVLPPQLSGRMTDEIHARLDVPDAQEVSCVRETGNTGNALPFFQLERLLPRMIAGDRAVGVA
>lobophorin_2
LQSGCTGAVQALDVARRLLGSGEHRTALVIGADSCAKHLDLSVDVRSLPPDQQVNGVLFGDGAGAAVLGVERGAHGVELLRTRVRC
>carbamidocyclophane_1
LADNNIESENIYRWIVHPGGPKVIDTVEAEFGLDSRTLQLSRDTLAEVGNISSATVLYMLDKVLSGEQSPPDSYGLVVAMGPGFAQEAILLKW
>tetronomycin_1
LQSGCSGAVQALSVAAGLLLSGSHRTALVLGGDVSAKLVDPDMDAAALPPAQLVNLMLFGDGAGALVLTAEPSPG
>tetronomycin_2
DWKADELAYVLPPQLSGRMTALIRERMGAPEAQEVSCVDETGNNGNALVFFQLARLLPKLTAGDRALGVA
>salinamide_1
YDLNAACAGFTYALAAAADAVRLGHVEHAVVIGSERLTDWTTPAIEDVYAMLADGAGAVVVSRAAEDGIGPPVWGSDG
>salinamide_2
CERAGTTVGDLDWLVMHQANRRILDAVAKDLGIDQDRVARDIIDAGNTSAASVPLALLALRESGATRPGESALFLGFGAGLTYAGQVVT
>napyradiomycin_2_1
HSWDAGKLDFYIVHAGGPRILDDLARFLDVDRQVFRHSWSTLTEYGNIASAVVFDAARRLFEEGSAKPDATGMIAGFGPGITAEMALG
>endophenazine_1
ELKQACYGATAALQFAIGLVHRDPAQQVLVVASDISKYELDSPGEATQGAAAVAMLVGSD
>endophenazine_2
FDVNAVCSGSVFALAVAEGLLAGRGGHALVIGADLYSRILNPADRRTVVLFGDGAGALVLGPAAQGPRVRHLALHT
>endophenazine_3
LHEAGVVPDDIGHFVPHQANGVLLDAVTADLGLPRAASHRTLAHYGNTGAASIPITLDTAARAGAFRPGDLILLAGFGGGMSAGLALVEW
>cosmomycin_d_1
EIRQVSNGGMAALDLAWAYLAADPARVAALLTTGDRFCPPGFDRWRSDPGTVYGDGGTALVVSRHSG
>cosmomycin_d_2
LADAGLGLADIDRFVLPHLGHRRLHVAYFAKFGIDPARSTWSWSRTIGHLGAGDPFAGLDHLATAGELGPGDTCLLFGVGAGFSWSCAVVEI
>WS9326_1
ASGLDAIRWGTALLRSGRADHVVVVGVEPDNEIARRLVGGPLADGAAAVVLERAEAAE
>WS9326_2
VSNACSASLYTLALGADLLALGEADTVIVAGVDSITESMHGLADRVQPNPPTALRTLDVNRRGTILGDGAAAVVLRGE
>WS9326_3
LSTACSAGAYAVGWGAELIETGQADVVVACGGDAFSRVAVGTLQRFGLLDGECCRPFDTGRAGMVTGEGAAALVLESAES
>pheganomycin_1
LRHSGVPPSRVGHWIVHSGGKKVIDAVRVNLGLTRHDVRHTTGVLRDHGNLSSGSFLFSYQRLAAEDRTRPGDHGVLMTMGPGSTIEMALARW
>pheganomycin_2
GMGCNAGLNALGSVAGWARTHPGELALMVCVEVCSAAYVFDGTLRSAVVNSLFGDGAAAVAVTAP
>phenolic_lipids_1
FAIHPGGPKIVDHVQEELGLAEDQVAISKSVFLENGNMSSSTIPHILKAYLEEATVGTRIACLGFGPGLTAAGLVLE
>phenolic_lipids_2
FAIHPGGPKIVEHIQEDLGLSDEQVAISKSVFLENGNMSSATIPHILKQVLEEVDVGTRVLCLGFGPGLTVTGMVLE
>flexirubin_2_1
VSNACVSGILAVSIAKRMIQSELYDNVFVVAGDEVSEFVLSGFNAFQAMSDLPCKPYSKNRTGVSLGEATAAVLVSANPATAK
>flexirubin_2_2
MDKNNIKSEDINYFIPHVSSNFFVEGLKKGLSEKGIGMSDEKWFMNLSRVGNVGSASIYLALEELMNSGNLKKGDHILLS
>lobosamide_1
LAVAGVTLDDIRLVLPHNVNVVTWHRLCRLIGLPRDRVLLDNVRDTGHVFCADAFANYLTARERGLLDPGDRYLVAAVGAGDGATFAAMV
>flexirubin_1
VSNACISGLLAILTARRLILSGRYDHAVVTGADVVTRFVLSGFQSFQAVSSEPCRPFDAERKGVTLGEGAATVILTSDQ
>versipelostatin_1
TSHDVAADGVDHFVPHQANGVLLNRLFPLLGLARARMHLTVAEHGNTSAASIPLALDHGNRTEAFHDGDLLLLAGFGGGMSIGTALVRW
>versipelostatin_2
FDINSVCSGFVFALVTAARLLSGRDTYGIVIGADIYSRIVDPTDRRTAVLFGDGAGAVVLGPVGPGQGLLGAELASHG
>versipelostatin_3
LDTLGWDETDVDYLLPPQLSGRMTRRITETLAVPGAHEVTLVDEIGNTGNAVAFFQLEHLLPRMSDGDRAI
>versipelostatin_4
LQSGCTGAVQALGVAWRMLRSGPERTALVLGAETSAKFFDLSADITDRPPAELINALLFGDGGGAAVLTKEPAPASPVL
>RK_682_1
LQSGCAGAVQALDVARTLLLAGRCSTVLVIGGDVCAKHLETDFDPGSRTPGELVNYILFGDGAGAAVLSAE
>RK_682_2
GWTADQVDYLLPPQLSGRMSDRISDAMPAPLAQRVNVVRTVGNNGNALPFLQLAELLGQWQGGGRAVTVA
>pamamycin_1
IERSGWTVEDVDRLATHQANARISEAVADELGVPRDRVLSNIEHVGNTSAASLPLLLADSAAAGRLRTNDRVLLAAFGGGLAWGAASLTW
>pamamycin_2
DVAAVCAGFLYALSAGVGAIAAGFADRVLVIGAETFSAIVDPQDRNTAVIFGDAAGAVVLRAGDPDEPGAIGPIRLGSDG
>pamamycin_3
FDVCAACVGFVHSVQTAAAMLTSHRWRHALVICSDQFSRRLKPGRRGSYVGGDGAGAAVLEVGAPDESRLRDSVV
>pamamycin_4
LRRNDMTIADVDRVVPHPGSARISEELVRRIGVAPERVLTNLRTRGQTTSATIPSALSEFTESGELRKGNVILSPAAGAGWFSGALLYQ
>pamamycin_5
FDVTAVACAGFLYASVVARGLLATTGARTALVVCAESPHAILNFGFKNSALFGAGAAAAVWRRGESSGGGADGLPTRSGMIDVVLRADG
>pamamycin_6
LKRNGLAPEQISWCIPHQANTNLLYPMADRLGIPRERMLLNLPRRGNTSSVGMPSALSEYVGDGTVKPGELLLGVSIGRGLSWGAMVFRY
>pamamycin_7
FEVCGSCAGFIQAVHTAASFLTAPTGYRKALVATTERVTRRVRPGSKGSMLVSDGAGACVLEATPGGSPGLIDSVFHTDG
>pamamycin_8
GRNKLAIGDIDWLIPHSGTEPLAKGIQHNLGADPARVLTNLAFRGNVSSASIPTTVSELRERGVVKPGDLVLSPSIGGGVWCWGSLLYRI
>A_90289_1
ELKQACYGATAALQFALGLVRRDPVQRVLVIASDISRYDLDSPGEATQGAAAVAMLVGSD
>A_90289_2
SLACAGGAQALVRATDLLRGRPGGKVLVVVAEVLSTTFHAHEDNIESMIYKVLFGDSAGACVVSDL
>diazepinomicin_1
ELKQACYGGTAGLQFAVGLVHRDPSQQVLVIASDVSKYALGEPGEATQGAAAVAMLVGAD
>clorobiocin_1
LRHGCNGTFSALELAVPYLRSAPHVGGALITASDNFGTPLIDRWNPGEGLAFLGDGAGAVVLGTSPGFAELLS
>clorobiocin_2
LHEAGVDARDIKTVVIHSMPRQAAASYLKILGFSLESSTWEFSRTTGHLGAGDHLAALHHLLSTGKVGPGDNLLLCGSSPGVTYKAAVIRI
>kendomycin_1
AGTSLRRSDIEHWVVHSGGKKVIDSVMVNLGLTRHDVRHTTGVLRDYGNLSSGSFLFSYERLLDSGVVRRGDYGVFMTMGPGSTIETALLRY
>galbonolides_1
LDETGVRPEGIARVVPIAIGAEVLDLLLGGAPLGLRAADTSWTFGRHLGHVGPCDVLLALDREFRSGTLRAGERVLVVSFGLGFRWTTALLEI
>cosmomycin_1
EIRQVSNGGMAALDLAWAYLAADPARVAALLTTGDRFCPPGFDRWRSDPGTVYGDGGTALVVSRHSG
>cosmomycin_2
LADAGLGLADIDRFVLPHLGHRRLHVAYFAKFGIDPARSTWSWSRTIGHLGAGDPFAGLDHLATAGELGPGDTCLLFGVGAGFSWSCAVVEI
>U_68204_1
LSVPPEEIRHFIPHQANGAMLRDIWGHMGLPRAHLHMPVARHGNTGAASIPIALDHAHRSDRLAAGDLVLLAGFGGGMTMATSLISW
>U_68204_2
FDVNAVCAGFVVALRAGASMALGDGRPGGRTLVIGSDVYSRIVDPSDRRTAPLFGDGAGAVVLGPVAEAGGFLGGSVA
>furaquinocin_a_1
QLGCAAGGAAINRAHDFCMAHPASNVLIVSCELCSPCYQPDADDIGSLLSDGLCGDAVAAAVVRGE
>furaquinocin_a_2
HSWDVGKLDFYIVHAGGPRILDDLARFLEVDREVFRHSWSTLHEFGNIASAVVLEAARGLFEEDALAPGATGLSAGVGPGITAE
>furaquinocin_a_3
ELKQACYAATAGLQFAIGLVRRDPAQRVLVVASDVSKYEPDSPGEATQGAAAVAMLVGAD
>furaquinocin_a_4
FDVNAVCSGEVFALAAAEGILTRRGGHALVIGADVYSRILNPADRRTVVLFGDGAGAMVLGPGRGARVRNLALHT
>furaquinocin_a_5
LHDSGVGPDDIRHFVPHQANGVMLDALFAELALNRAVMHRTLTHYGNTGAASIPITLAEAARSGAFRPGDLILLAGFGGGMAVGFALVEW
>pactamycin_1
EAGITVPDLSHVLHLGAATTDFLDSHLRPMGLDASLGSVEFFRDVGHAGAADVGIHLDHLACSGRLAAGDHLLMLSAGPGLMITAAVVT
>pactamycin_2
VEQGCNAFLAALEMATQYLLCAPTRSGAVVSAADNFGAPSVDRWHAHRDSVLADAGAAVVLSKR
>cervnimycin_1
LAQRCNGGMGAIELAGAYLGSGIGAGHAALLTTGDRFAGPRIDRWNSVDVTMYGDGAAALVLSTRDGFARVLSTATGVD
>cervnimycin_2
LEDAGTAIEDIAHAVIPVSRRGTGHELHDLLGLPDERTSWAYGRTTGHVGAGDQYAGLAHLVENALVQPGDRVLLFGGGAGYTCTAAVVEI
>pseudopyronine_1
QNLTADDVHKVFIHTGSPKMWEHIGQMIGVDHKLHHVGHKTGNIITASIPFGIFDAMSRGEAEPGQFCMGWAGSGGMVFSALS
>flaviolin_1
DHRWDVAGLDFYVIHAGGPRILDDLTKFLGVPSEAFRHSRATLAQYGNIASAVVLDALRRIIEEGRLESGARGMIAGFGPGITAEMSV
>eicosapentaenoic_acid_4_1
LAQRDWVVENVDKVICHQVGASNRRQVLNALNIPVNKEFPTYKLMGNMGSVSLPATAAMAHDHGFLKSGDNVSFLGIGSGLNCMMLGLKW
>eicosapentaenoic_acid_4_2
YDISNACLGVLSGILDIANRIELGQIKAGLVVSCESARHIVDITIDHMLAEPTMQNFAQSLATLTGGSGAVAVILTDGSLPLRN
>kijanimicin_1
LDALDWDRGELDYVLPPQLSGRMTDAILARLDVPDAREVSCVRETGNTGNALPFFQLERLLPHMITGDR
>kijanimicin_2
LQSGCAGAVQALDVARRLLRSGEHRTALVLGADSCARHLDLTVDVSALPPGEQVNGVLFGDGAGAAVLGTKPGDNGI
